NCT01130649

Brief Summary

The investigators propose a novel method for tracking the seizure frequency, side effect burden, and medication compliance for patients with epilepsy. The investigators intend to utilize a table-top device currently for tracking other chronic disease to collect remote data from epilepsy patients. The hypothesis is that the use of this device will lead to better longterm treatment outcomes than the standard outpatient mechanism of following patients longitudinally.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 26, 2010

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2010

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

May 3, 2017

Status Verified

May 1, 2017

Enrollment Period

1 year

First QC Date

May 24, 2010

Last Update Submit

May 1, 2017

Conditions

Keywords

EpilepsyTrackingElectronic diary

Outcome Measures

Primary Outcomes (3)

  • Seizure frequency per month

    Assessment of seizure count accuracy by assessing total number of seizures reported per month

    1 year

  • Medication compliance

    Assessment of compliance with taking medications at regularly scheduled intervals

    1 year

  • Quality of life

    Quality of Life in Epilepsy inventory, to assess for overall change in quality of life measures

    1 year

Study Arms (2)

Epilepsy patients, electronic diary

Cohort of epilepsy patient using an electronic diary system to record all seizures, side effects, and medication compliance

Device: HealthBuddy

Epilpesy patient, no electronic diary

Group of epilepsy patients who are followed using the standard of care, which is a paper diary and routine outpatient follow up visits

Interventions

Noninvasive device for remotely reporting health information. The device does nothing to change the health of the patient, but transmits health data that is entered by the patient directly to the physician's office. Patients will enter data on seizure frequency, medication compliance, and side effects.

Also known as: Healthbuddy is a product of Bosch Healthcare, and is already utilized in many medical institutions around the country, including the VA Health System.
Epilepsy patients, electronic diary

Eligibility Criteria

Age6 Months - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients will be recruited from the UCSF and VAMC Outpatient Epilepsy Centers. All study participants must have a confirmed diagnosis of epilepsy (defined by two or more unprovoked seizures) for at least 6 months.

You may qualify if:

  • Patient can range in age from birth to 65 years old; in cases of child participants, the parents are responsible for data reporting.
  • Patients must have a seizure frequency of at least two seizures in a 6 month period of time.
  • Patients must be on at least one anti-epileptic medication.
  • Patients and/or legal guardian must be able to report seizure frequency with either a paper or electronic diary.
  • Patients and/or legal guardians must be able to read and understand either English or Spanish.
  • Patients and/or legal guardians must be able to complete questionnaires and provide informed consent to this study.

You may not qualify if:

  • Recent problem with substance abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univ of California San Fran

San Francisco, California, 94143, United States

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • John Hixson, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Neurology

Study Record Dates

First Submitted

May 24, 2010

First Posted

May 26, 2010

Study Start

July 1, 2010

Primary Completion

July 1, 2011

Study Completion

July 1, 2013

Last Updated

May 3, 2017

Record last verified: 2017-05

Locations